Work

Supplementary Figures S1-S5 from Combined Blockade of Src Kinase and Epidermal Growth Factor Receptor with Gemcitabine Overcomes STAT3-Mediated Resistance of Inhibition of Pancreatic Tumor Growth

Year: 2023
Type: supplementary-materials
Abstract: Supplementary Figures S1-S5.
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
OpenAlex ID: W4361819161
Cites:
Cited by:
Related to: 10